Q1 Earnings Estimate for ARDT Issued By Leerink Partnrs

Ardent Health Partners, LLC (NYSE:ARDT) – Equities researchers at Leerink Partnrs dropped their Q1 2025 earnings estimates for Ardent Health Partners in a note issued to investors on Monday, November 11th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $0.35 for the quarter, down from their prior estimate of $0.39. Leerink Partnrs has a “Strong-Buy” rating on the stock. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.25 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q2 2025 earnings at $0.58 EPS, Q3 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.56 EPS, FY2025 earnings at $1.99 EPS, FY2026 earnings at $2.27 EPS and FY2027 earnings at $2.51 EPS.

A number of other brokerages have also recently issued reports on ARDT. Royal Bank of Canada assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued an “outperform” rating and a $23.00 target price for the company. Loop Capital began coverage on Ardent Health Partners in a report on Monday, August 12th. They set a “buy” rating and a $18.00 price objective for the company. KeyCorp started coverage on Ardent Health Partners in a research report on Friday, October 11th. They issued an “overweight” rating and a $24.00 price target for the company. Truist Financial initiated coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They issued a “buy” rating and a $21.00 price objective on the stock. Finally, Mizuho assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set an “outperform” rating and a $20.00 target price for the company. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $21.82.

Ardent Health Partners Price Performance

NYSE ARDT opened at $17.01 on Thursday. The business’s 50-day moving average price is $18.27. Ardent Health Partners has a 52-week low of $14.57 and a 52-week high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Ardent Health Partners (NYSE:ARDT) last released its earnings results on Wednesday, August 14th. The company reported $0.35 EPS for the quarter, topping the consensus estimate of $0.30 by $0.05. The firm had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion.

Institutional Trading of Ardent Health Partners

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Allspring Global Investments Holdings LLC acquired a new position in shares of Ardent Health Partners during the third quarter worth about $13,119,000. Seven Grand Managers LLC bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth about $2,298,000. Charles Schwab Investment Management Inc. bought a new position in shares of Ardent Health Partners during the third quarter worth about $526,000. MetLife Investment Management LLC acquired a new position in shares of Ardent Health Partners in the 3rd quarter worth approximately $135,000. Finally, Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at approximately $50,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.